✦ LIBER ✦

A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer

✍ Scribed by Lee, Jeeyun; Shin, Sang Joon; Chung, Ik Joo; Kim, Tae Won; Chun, Hoo-Geun; Shin, Dong Bok; Kim, Yeul Hong; Song, Hong Suk; Han, Sae-Won; Kim, Jong Gwang; Kim, Sun Young; Choi, Young Jin; Chung, Hyun Cheol

Book ID: 121541062
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 313 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-014-0075-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of S-1 with oxaliplatin

A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer

✍ Hyeong Su Kim; Min Jae Park; Ji Eun Uhm; Yuna Lee; Hui Young Lee; Eun Mi Kang; J 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 111 KB

Leucovorin, fluorouracil, and oxaliplati

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

✍ Yamada, Yasuhide; Takahari, Daisuke; Matsumoto, Hiroshi; Baba, Hideo; Nakamura, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 438 KB

6118 POSTER Randomized Phase II Study of

6118 POSTER Randomized Phase II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) Versus MFOLFOX6 in Patients With Untreated Metastatic Colorectal Cancer (mCRC)

✍ Ojima, H.; Yamazaki, K.; Kuwano, H.; Otsuji, T.; Kato, T.; Shimada, K.; Denda, T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Front-line Bevacizumab in combination wi

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

Phase II study of biweekly S-1 and oxali

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

✍ Junshik Hong; Sae-Won Han; Hye Seon Ham; Tae-Yong Kim; In Sil Choi; Byung-Su Kim 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 257 KB

Phase I/II trial of capecitabine and oxa

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

✍ Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB